Back to Search

MAEN ABDELRAHIM, MD

MD

Medical Oncology Physician

NPI: 1518227735IndividualAccepts Medicare

Specialties, Licenses & Credentials

Internal Medicine Physician

Internal Medicine

Code: 207R00000X

BP10043067(TX)
Medical Oncology PhysicianPrimary

Internal Medicine — Medical Oncology

Code: 207RX0202X

Q1781(TX)

CMS Specialties

PrimaryMEDICAL ONCOLOGY

Education

TEXAS A & M UNIVERSITY SYSTEM, HSC, COLLEGE OF MEDICINE

Class of 2012

Research & Publications (20)

Regulation of vascular endothelial growth factor receptor-1 expression by specificity proteins 1, 3, and 4 in pancreatic cancer cells.
PMID 17409437·Cancer Res·2007
8-other
Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation.
PMID 16788159·J Natl Cancer Inst·2006
7-preclinical
3-Methylcholanthrene and other aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha.
PMID 16489053·Cancer Res·2006
7-preclinical
3,3'-diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5.
PMID 16332727·Carcinogenesis·2006
8-other
Induction of endoplasmic reticulum-induced stress genes in Panc-1 pancreatic cancer cells is dependent on Sp proteins.
PMID 15760841·J Biol Chem·2005
8-other
Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins.
PMID 15883203·Mol Pharmacol·2005
4-observational
Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells.
PMID 12761348·Mol Pharmacol·2003
8-other
Stanniocalcin-1 suppresses superoxide generation in macrophages through induction of mitochondrial UCP2.
PMID 19602668·J Leukoc Biol·2009
7-preclinical
Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells.
PMID 19582879·Int J Cancer·2009
7-preclinical
The nonsteroidal anti-inflammatory drug tolfenamic acid inhibits BT474 and SKBR3 breast cancer cell and tumor growth by repressing erbB2 expression.
PMID 19435870·Mol Cancer Ther·2009
7-preclinical
Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met.
PMID 19406933·Carcinogenesis·2009
7-preclinical
Aerodynamic characteristics of nebulized terbutaline sulphate using the Next Generation Impactor (NGI) and CEN method.
PMID 19392586·J Aerosol Med Pulm Drug Deliv·2009
8-other
Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression.
PMID 19258429·Mol Cancer Ther·2009
7-preclinical
1,1-bis(3'-indolyl)-1-(p-methoxyphenyl)methane activates Nur77-independent proapoptotic responses in colon cancer cells.
PMID 17957723·Mol Carcinog·2008
8-other
Structure-dependent activation of endoplasmic reticulum stress-mediated apoptosis in pancreatic cancer by 1,1-bis(3'-indoly)-1-(p-substituted phenyl)methanes.
PMID 18852139·Mol Cancer Ther·2008
8-other
5,5'-Dibromo-bis(3'-indolyl)methane induces Kruppel-like factor 4 and p21 in colon cancer cells.
PMID 18645021·Mol Cancer Ther·2008
7-preclinical
1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through activation of c-jun N-terminal kinase.
PMID 18460448·Carcinogenesis·2008
7-preclinical
Vascular endothelial growth factor receptor-2 expression is down-regulated by 17beta-estradiol in MCF-7 breast cancer cells by estrogen receptor alpha/Sp proteins.
PMID 18006642·Mol Endocrinol·2008
8-other
1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce apoptosis and inhibit renal cell carcinoma growth.
PMID 18006776·Clin Cancer Res·2007
7-preclinical
Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor-dependent and nuclear receptor-independent pathways.
PMID 17234778·Cancer Res·2007
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 2 locations total

Address
1709 Dryden Rd Ste 5.78, Faculty Center, BCM 620
Houston, TX 77030

Locations (2)

Practice Location

1709 Dryden Rd Ste 5.78, Houston, TX
(713) 798-0190

Practice Location

6445 MAIN STREET, OPC24, HOUSTON, TX
(713) 441-9948

Quick Facts

NPI
1518227735
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
2
Years in Practice
14
Publications
20

Are you this provider?

Claim Your Profile